NCT03442569 PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC Status COMPLETED Phase PHASE2
NCT03433755 Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia Status TERMINATED Phase PHASE3
NCT03432533 A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis Status COMPLETED Phase PHASE3
NCT03430687 Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma Status WITHDRAWN Phase PHASE1
NCT03422627 Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease Status TERMINATED Phase PHASE1/PHASE2
NCT03410056 Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis Status TERMINATED Phase PHASE1/PHASE2
NCT03406078 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma Status COMPLETED Phase PHASE3
NCT03403374 Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE4
NCT03398954 a Prospective Pilot Study of Screening Out Rate and Clinical Management of Familial Hypercholesterolemia Status UNKNOWN Phase N/A
NCT03392064 A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC Status SUSPENDED Phase PHASE1
NCT03387605 Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine Status UNKNOWN Phase PHASE4
NCT03362177 Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer Status COMPLETED Phase PHASE3
NCT03347279 Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma Status COMPLETED Phase PHASE3
NCT03343847 Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma. Status WITHDRAWN Phase PHASE3
NCT03340766 Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE1
NCT03335488 Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs) Status COMPLETED Phase PHASE4
NCT03319940 Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE1